---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-026697"
form_type: "8-K"
ticker: "IMMX"
cik: "0001873835"
company_name: "Immix Biopharma, Inc."
filed_at: "2025-12-08T23:59:59+00:00"
generated_at: "2026-05-16T14:05:21.808019+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Immix Biopharma raises ~$93.7M net via 19.1M share and warrant offering at $5.10

## Summary
- 19,117,646 shares at $5.10/share and 490,196 pre-funded warrants at $5.09/warrant in underwritten offering.
- Net proceeds expected ~$93.7M after underwriting discounts and estimated expenses.
- Underwriting agreement with Morgan Stanley & Co. LLC as representative of underwriters.
- Offering expected to close December 9, 2025, subject to customary closing conditions.
- Pre-funded warrants exercisable immediately at $0.01/share, with 4.99% beneficial ownership limitation.

## SEC filing metadata
- accession: 0001493152-25-026697
- form_type: 8-K
- ticker: IMMX
- cik: 0001873835
- company_name: Immix Biopharma, Inc.
- filed_at: 2025-12-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1873835/000149315225026697/0001493152-25-026697-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1873835/000149315225026697/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-026697
- JSON: https://secwatch.observer/filing/0001493152-25-026697.json
- Plain text: https://secwatch.observer/filing/0001493152-25-026697.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.